trending Market Intelligence /marketintelligence/en/news-insights/trending/AsIMmOCjHb9izVXPGDHp_A2 content esgSubNav
In This List

Achillion Pharmaceuticals' chief medical officer resigns

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Achillion Pharmaceuticals' chief medical officer resigns

David Apelian resigned as executive vice president and chief medical officer of Achillion Pharmaceuticals Inc., effective Dec. 28.

Apelian resigned to pursue another professional opportunity

The company has started searching for a new chief medical officer.